GEN - Genetic Engineering and Biotechnology News

Drug Discovery Innovation: Target Deconvolution and Tractability Assessment

In this GEN webinar, our expert speakers will explore cutting-edge drug discovery techniques for target deconvolution and multiplex target discovery.

OncoPrecision Announces Oral Presentation of ONC001, a First-in-Class CD64-Targeting ADC for Monocytic Leukemia, at the 67th ASH Annual Meeting

ONC001 is a first-in-class antibody-drug conjugate (ADC) designed to uniquely target CD64, a myeloid-restricted receptor pervasively expressed in CMML and M4/M5 acute myeloid leukemia, including ...
The Manila Times

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed AML ...

Prescient Therapeutics Limited (PSTTF) Discusses EMA Orphan Drug Designation and Clinical Progress of PTX-100 for CTCL Transcript

And they received FDA support for Orphan Drug Designation and Fast Track Designation and they've got the opportunity to look at the IIb turning into a registration study, and that opens up the ...

Parexel Showcases Industry-Leading Hematology Expertise with Presentation of 10 Research Posters at the American Society of Hematology (ASH) Annual Meeting

"Our significant showcase at ASH this year reflects Parexel’s specialized scientific and medical expertise in hematology and our commitment to partnering with leading biopharma sponsors to advance ...

Life Sciences BPO Market is expected to generate a revenue of USD 481.8 Billion by 2032, Globally, at 7.50% CAGR: Verified Market Research (R) - MarketWatch

The Life Sciences BPO Market is expanding rapidly, driven by rising R&D costs, increasing regulatory complexities and the growing need for operational efficiency across pharma and biotech sectors.

Structure: Maintaining Strong Buy As Aleniglipron Succeeds In Obesity Study Program

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...
Vanguard

NAFDAC makes history, joins world’s top drug regulators in ICH

Nigeria becomes the 24th out of only 25 NRAs worldwide recognised for commitment to globally harmonised pharmaceutical standards ...
TMCnet

Life Sciences BPO Market is expected to generate a revenue of USD 481.8 Billion by 2032, Globally, at 7.50% CAGR: Verified Market Research®

The Global Life Sciences BPO Market Size projected to grow at a CAGR of 7.50% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that the market ...

Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs

The Deciparticle ™ platform is a proprietary nanotechnology engineered to encapsulate hydrophobic molecules as uniform, sub-20 nm nanoparticles for intravenous administration. The platform improves ...
TMCnet

Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ST-503, an investigational ...
Corporate Compliance Insights

The FDA’s Prescription for Balanced Messaging Applies Beyond Pharma

While pharmaceutical companies face some of the most stringent product marketing requirements in the US, the regulatory ...